Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...
Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...
Timothy Ray Brown, known as the "Berlin Patient" and the first person to have been cured of HIV, pictured in 2012. Since the landmark stem cell transplantation which saw Timothy Ray Brown become the ...
Researchers found that lithium can suppress HIV reactivation in lab-grown human cells through an unexpected, ...
Researchers revealed on Tuesday that an American, described as a middle-aged woman of mixed race, has likely been cured of HIV after undergoing a new transplant procedure using donated umbilical cord ...
A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...
Around the world, some 40 million people are living with HIV. And though progress in treatment means the infection isn’t the death sentence it once was, researchers have never been able to bring about ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback